SOHM Posts FH2013 Financial Results, Provides Full-Year Outlook
19 Novembro 2013 - 11:30AM
Marketwired
SOHM Posts FH2013 Financial Results, Provides Full-Year Outlook
Revenues in the First-Half of 2013 Expected to Exceed Total
Revenues Achieved in Full-Year 2012
BUENA PARK, CA--(Marketwired - Nov 19, 2013) - SOHM, Inc.
(PINKSHEETS: SHMN), a company that manufactures and markets generic
pharmaceuticals, nutraceutical and cosmeceuticals covering all
major treatment categories, today announces its financial results
for the first six months of 2013, as well as provides guidance for
the full year.
SOHM reports revenue growth of 116 percent for the first six
months of 2013, compared to revenues in the comparable period of
2012. Nine months revenue of $1,539,055 has already surpassed
revenue of $1,296,450 achieved during the full year of 2012. By end
of fiscal year 2013, SOHM projects revenue growth of more
than 55 percent as compared to 2012.
Shailesh Shah, president and CEO of SOHM, stated, "SOHM is
confident for its outlook for the year 2013 and beyond for its
continued growth due to focused approach. This year we have
introduced to market two exciting new skin care product lines to
U.S. consumers, as well as a unique protein supplement in
India."
The launch of I-Prolec protein supplement in the Indian market
adds weight to SOHM's confidence in its product offerings, and
creates a new and valuable stream of revenue generation.
"Success of our I-Prolec supplement, Salic-2 Gel and Fohm by
Sohm face wash products, and nine over-the-counter medicines
packaged in travel packs, support the projected financial growth
and profitability we expect to achieve during 2014," Shah
stated.
About SOHM, Inc. SOHM, Inc. is a generic pharmaceutical
manufacturer that produces and markets generic drugs covering all
major treatment categories. Besides generic drugs, SOHM also has
manufacturing facilities for food supplements and cosmetics. The
Company has global headquarters located in California, U.S., with
manufacturing facilities in India. SOHM exports generic
pharmaceuticals worldwide, placing a heavy focus on distribution in
emerging markets in Africa, Latin America, and Southeast Asia. For
more information visit the company's website at: www.sohm.com
Safe Harbor Statement This press release contains statements,
which may constitute "forward-looking statements" within the
meaning of the Securities Act of 1933 and the Securities Exchange
Act of 1934, as amended by the Private Securities Litigation Reform
Act of 1995. Those statements include statements regarding the
intent, belief or current expectations of SOHM, Inc., and members
of their management as well as the assumptions on which such
statements are based. Prospective investors are cautioned that any
such forward-looking statements are not guarantees of future
performance and involve risks and uncertainties, and that actual
results may differ materially from those contemplated by such
forward-looking statements. Important factors currently known to
management that could cause actual results to differ materially
from those in forward-statements include fluctuation of operating
results, the ability to compete successfully and the ability to
complete before-mentioned transactions. The company undertakes no
obligation to update or revise forward-looking statements to
reflect changed assumptions, the statements to reflect changed
assumptions, the occurrence of unanticipated events or changes to
future operating results.
For more information, please contact: SOHM, Inc. Investor
Relations (714) 522-6700
SOHM (PK) (USOTC:SHMN)
Gráfico Histórico do Ativo
De Out 2024 até Nov 2024
SOHM (PK) (USOTC:SHMN)
Gráfico Histórico do Ativo
De Nov 2023 até Nov 2024